These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8196094)

  • 21. Pharmacokinetics, bioavailability and dosage regimen of sulphadimidine in camels (Camelus dromedarius) under hot, arid environmental conditions.
    Kumar R; Singh AP; Rai AK
    Vet Res; 1999; 30(1):39-47. PubMed ID: 10081111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and intramuscular bioavailability of amikacin in chickens following single and multiple dosing.
    el-Gammal AA; Ravis WR; Krista LM; Tolbert DS; Saad A
    J Vet Pharmacol Ther; 1992 Jun; 15(2):133-42. PubMed ID: 1433475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers.
    Champoux N; Du Souich P; Ravaoarinoro M; Phaneuf D; Latour J; Cusson JR
    Br J Clin Pharmacol; 1996 Sep; 42(3):325-31. PubMed ID: 8877023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics and plasma protein binding of sulfamethoxypyridazine in camels (Camelus dromedarius)].
    Abdennebi EH; Bousfiha A; Ben Goumi M; Oukessou M
    Rev Elev Med Vet Pays Trop; 1994; 47(1):97-102. PubMed ID: 7991901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats.
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    J Pharm Pharmacol; 1993 Nov; 45(11):971-4. PubMed ID: 7908039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma disposition of cefoperazone after single intravenous and intramuscular administrations in camels (Camelus dromedarius).
    Aboubakr M; Soliman A; Uney K; Elmas M
    Acta Vet Hung; 2018 Sep; 66(3):444-450. PubMed ID: 30264621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats.
    Ali BH; Al-Qarawi AA; Hashaad M
    Vet Res Commun; 2003 Sep; 27(6):475-83. PubMed ID: 14582746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic disposition of flunixin meglumine in the camel (Camelus dromedarius).
    Oukessou M
    Vet Res; 1994; 25(1):71-5. PubMed ID: 8142960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and distribution of ceftazidime to milk after intravenous and intramuscular administration to lactating female dromedary camels (Camelus dromedarius).
    Goudah AM; Hasabelnaby SM
    J Am Vet Med Assoc; 2013 Aug; 243(3):424-9. PubMed ID: 23865886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The disposition of five therapeutically important antimicrobial agents in llamas.
    Christensen JM; Smith BB; Murdane SB; Hollingshead N
    J Vet Pharmacol Ther; 1996 Dec; 19(6):431-8. PubMed ID: 8971671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of the literature (1995-1999) on the kinetics of drugs in camels (Camelus dromedarius).
    Alquarawi AA; Ali BH
    Vet Res Commun; 2000 May; 24(4):245-60. PubMed ID: 10836270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of tobramycin.
    Aarons L; Vozeh S; Wenk M; Weiss P; Follath F
    Br J Clin Pharmacol; 1989 Sep; 28(3):305-14. PubMed ID: 2789924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis.
    Cooney GF; Lum BL; Tomaselli M; Fiel SB
    J Clin Pharmacol; 1994 Mar; 34(3):255-9. PubMed ID: 8021334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic evaluation of tobramycin in the alveolar lining fluid of the rat after endotracheal administration.
    Valcke YJ; Pauwels RA
    Am Rev Respir Dis; 1991 Nov; 144(5):1199-201. PubMed ID: 1952452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics, metabolism and urinary detection time of tramadol in camels.
    Elghazali M; Barezaik IM; Abdel Hadi AA; Eltayeb FM; Al Masri J; Wasfi IA
    Vet J; 2008 Nov; 178(2):272-7. PubMed ID: 17904881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.